Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × gadolinium ethoxybenzyl DTPA × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 12 Liver Neoplasms 3 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Neuroendocrine Tumors 1 Liver Diseases 1 Liver Abscess 1 Digestive System Diseases 1 Carcinoma 1 Breast Neoplasms 1 Adenoma 1

Interventions

Sorafenib 5 Blood Specimen Collection 4 pembrolizumab 2 lenvatinib 2 ledipasvir, sofosbuvir drug combination 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Liver Transplantation 2 Immunotherapy 2 Control Groups 2 Bevacizumab 2 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 sintilimab 1 rubitecan 1 repotrectinib 1 pevonedistat 1 ozanimod 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1 durvalumab 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490203 2018-03-23

LiFE

Seoul National University Hospital

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡